ArticleJournal of translational medicine2022

The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics.

Yan Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.